NovaDel's NitroMist Is "Approvable" At FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The company expects full approval for the 505(b)(2) product following completion of manufacturing validation commitments. Par will co-promote the product, which administers nitroglycerine to the oral mucosa.